вторник, 26 января 2016 г.

Biotech Weekly: The NASDAQ Sub $10 Million Market Cap Club

Biotech Weekly: The NASDAQ Sub $10 Million Market Cap Club


Reasons to review the NASDAQ sub $10 million market cap list include the value of a NASDAQ listing, significant remaining assets, overly negative sentiment, and ignored upside scenarios. Current sub $10 million market cap NASDAQ biotechs include Cellectar Biosciences, Nanosphere, Lpath, Signal Genetics, Venaxis, TetraLogic Pharmaceuticals, Eleven Biotherapeutics, and GenVec.



from Biotech News